Recombinant Human BARK Protein，His & GST

BARK (B-Alpha Receptor Kinase) is a member of a group of protein kinases that play a critical role in regulating G protein-coupled receptor (GPCR) signaling, a fundamental pathway implicated in numerous physiological processes and diseases. With the discovery that BARK selectively phosphorylates activated GPCRs, researchers have become increasingly interested in its potential as a therapeutic target for conditions such as heart disease, neurodegenerative disorders, and cancer. The understanding of BARK's structure and function was significantly enhanced through the development of recombinant protein technology, allowing for the expression and purification of BARK in sufficient quantities for detailed biochemical studies. Researchers have utilized various techniques, including site-directed mutagenesis and crystallography, to elucidate the molecular mechanisms underlying BARK's role in modulating GPCR activity. This research is crucial for uncovering the intricacies of cell signaling pathways and developing innovative drug strategies aimed at influencing BARK activity to restore normal function in disease states. As a result, BARK has emerged as a promising candidate in the field of pharmacology and drug design, making its study not only academically intriguing but also of significant clinical relevance.